Managing Hereditary Spherocytosis: Treatment and Surgical Options
Last updated:
Treatment for hereditary spherocytosis (HS) is tailored to the severity of the condition. Mild cases are managed with folic acid and monitoring, while severe cases may require blood transfusions or a splenectomy. Surgery is generally delayed until age 6 to protect the developing immune system.
Key Takeaways
- • Mild hereditary spherocytosis is generally managed with routine monitoring and daily folic acid supplements.
- • Severe cases may require red blood cell transfusions or surgical removal of the spleen (splenectomy) to manage anemia.
- • Splenectomy is typically delayed until a child is at least six years old to reduce the risk of severe infections.
- • A partial splenectomy preserves some immune function, but carries a risk that a second surgery may be needed later.
- • Patients without a functioning spleen must follow a strict lifelong protocol for vaccinations, antibiotics, and fever management.
Deciding on the best treatment for Hereditary Spherocytosis (HS) is a collaborative process between you, hematologists, and surgeons. Because the condition ranges from very mild to severe, treatment is tailored to the individual. It is important to remember that while medical and surgical treatments can effectively “cure” the symptoms of HS (like anemia and jaundice), they do not change the underlying genetic blueprint of the red blood cells [1][2].
Standard Care and Monitoring
Treatment for HS varies significantly based on the severity of the condition [3].
For Mild HS:
- Monitoring: Regular blood tests (often every 6 to 12 months, or as directed) to check hemoglobin levels and reticulocyte counts [3].
- Folic Acid: Folic acid is a standard daily supplement often prescribed to support the bone marrow’s massive, continuous demand for producing new red blood cells and to prevent a megaloblastic crisis [4][5].
For Moderate to Severe HS:
- Transfusions: A patient may need a red blood cell transfusion to boost oxygen levels, particularly if anemia is severe or during an aplastic crisis (a sudden stop in red blood cell production) [1][6].
The Splenectomy Decision
When anemia is severe, or the spleen is so large it causes discomfort, a splenectomy (surgical removal of the spleen) may be considered [1][6].
Delaying Surgery to Protect Immunity
Doctors generally recommend delaying any surgery on the spleen until a child is at least 6 years old [6][7]. This is because the spleen plays a vital role in the early development of the immune system. Removing it too early significantly increases the risk of Overwhelming Post-Splenectomy Infection (OPSI)—a rare but life-threatening infection caused by certain bacteria like Streptococcus pneumoniae [8][9].
Total vs. Partial Splenectomy
Modern surgery offers two main options, each with its own trade-offs:
- Total Splenectomy (TS): The entire spleen is removed. This provides the most complete “cure” for anemia and jaundice because it removes the site where red blood cells are destroyed [2][10]. However, it carries the highest lifelong risk of infection [8].
- Partial Splenectomy (PS): The surgeon removes a large portion of the spleen but leaves a small “remnant” behind (usually about 15–20%) [2][1].
- The Benefit: The remaining tissue continues to provide some immune protection, lowering the risk of OPSI [1][11].
- The Risk: In about 24% to 42% of cases, the remaining spleen tissue can grow back or continue to destroy enough red blood cells that a second surgery (to remove the rest) is eventually needed [12][13][14].
Managing Gallstones
Because of the constant breakdown of red blood cells, many people with HS develop gallstones (cholelithiasis) [15][3].
- Ultrasound Screening: Doctors use regular ultrasounds to check the gallbladder for stones [15][16].
- Concurrent Surgery: If a patient needs a splenectomy and already has gallstones, the surgeon will usually perform a cholecystectomy (gallbladder removal) during the same operation to resolve the issue [17][18]. Surgery to remove a healthy gallbladder in the absence of gallstones is generally not recommended due to unnecessary surgical risks [17].
Protecting the Immune System
If any part of the spleen is removed, lifelong vigilance is required:
- Vaccinations: Patients must be fully vaccinated against specific encapsulated bacteria (Pneumococcus, Meningococcus, and Hib) at least 2 weeks (ideally 10 to 14 days) prior to a planned splenectomy to ensure optimal immune response while the spleen is still intact [19][8].
- Antibiotics: Many doctors prescribe daily preventive antibiotics (like penicillin) for several years after surgery to further reduce infection risk [19][8].
- Fever Protocol: Any fever in a person without a functioning spleen is treated as a potential medical emergency requiring immediate evaluation [8].
Frequently Asked Questions
What is the standard treatment for mild hereditary spherocytosis?
Why do doctors wait to perform a splenectomy on a child with HS?
What is the difference between a total and partial splenectomy?
Why might I need my gallbladder removed if I have hereditary spherocytosis?
How is my immune system protected after my spleen is removed?
Questions for Your Doctor
- • Based on the current hemoglobin and transfusion needs, is surgery recommended now or can we wait?
- • If we choose a partial splenectomy, what is the specific risk that a second surgery to remove the rest of the spleen will be needed later?
- • What is the precise vaccination schedule we must follow before the splenectomy is performed?
- • How will immune system health be monitored after the surgery to ensure protection against infections?
Questions for You
- • How has my or my child's quality of life been affected by anemia, fatigue, or frequent jaundice episodes?
- • Am I prepared to follow a strict, long-term protocol for vaccinations and antibiotics if the spleen is removed?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Surgical management of hereditary spherocytosis Current strategies.
Vecchio R, Cacciola E, Cacciola RR, Intagliata E
Annali italiani di chirurgia 2018; (89()):473-478.
PMID: 30665218 - 2
Hereditary Spherocytosis - Diagnosis, Surgical Treatment and Outcomes. A Literature Review.
Manciu S, Matei E, Trandafir B
Chirurgia (Bucharest, Romania : 1990) 2017; (112(2)):110-116.
PMID: 28463670 - 3
Hereditary spherocytosis: Retrospective evaluation of 65 children.
Güngör A, Yaralı N, Fettah A, et al.
The Turkish journal of pediatrics 2018; (60(3)):264-269.
PMID: 30511538 - 4
An overview of hereditary spherocytosis and the curative effects of splenectomy.
Turpaev K, Bovt E, Shakhidzhanov S, et al.
Frontiers in physiology 2025; (16()):1497588 doi:10.3389/fphys.2025.1497588.
PMID: 40008208 - 5
Hereditary Spherocytosis Unmasked by Human Parvovirus B19 Induced Aplastic Crisis in a Family.
Alavi S, Arabi N, Yazdi MK, et al.
Iranian journal of medical sciences 2015; (40(5)):461-4.
PMID: 26379354 - 6
Temporal trends of splenectomy in pediatric hospitalizations with hereditary spherocytosis from 2000 to 2019: A national survey.
Guizzetti L
Pediatric blood & cancer 2024; (71(4)):e30869 doi:10.1002/pbc.30869.
PMID: 38316689 - 7
Hereditary spherocytosis before and after splenectomy and risk of hospitalization for infection.
Liu Y, Jin S, Xu R, et al.
Pediatric research 2023; (93(5)):1336-1341 doi:10.1038/s41390-022-02229-y.
PMID: 35915237 - 8
Post-splenectomy sepsis: preventative strategies, challenges, and solutions.
Luu S, Spelman D, Woolley IJ
Infection and drug resistance 2019; (12()):2839-2851 doi:10.2147/IDR.S179902.
PMID: 31571940 - 9
Pneumococcal purpura fulminans in asplenic or hyposplenic patients: a French multicenter exposed-unexposed retrospective cohort study.
Contou D, Coudroy R, Colin G, et al.
Critical care (London, England) 2020; (24(1)):68 doi:10.1186/s13054-020-2769-y.
PMID: 32102696 - 10
Total versus partial splenectomy in pediatric hereditary spherocytosis: A systematic review and meta-analysis.
Guizzetti L
Pediatric blood & cancer 2016; (63(10)):1713-22 doi:10.1002/pbc.26106.
PMID: 27300151 - 11
Super-Selective Partial Splenic Embolization for Hereditary Spherocytosis in Children: A Single-Center Retrospective Study.
Wang RJ, Xiao L, Xu XM, et al.
Frontiers in surgery 2022; (9()):835430 doi:10.3389/fsurg.2022.835430.
PMID: 35284491 - 12
Clinical and laboratory outcomes following total or partial splenectomy in patients with hereditary spherocytosis.
Tripodi SI, Shamberger RC, Heeney MM, Tubman VN
Pediatric hematology and oncology 2019; (36(6)):382-389 doi:10.1080/08880018.2019.1637983.
PMID: 31347415 - 13
Partial splenectomy in children: Long-term reoperative outcomes☆.
Hafezi N, Carpenter KL, Colgate CL, et al.
Journal of pediatric surgery 2021; (56(11)):1998-2004 doi:10.1016/j.jpedsurg.2021.01.005.
PMID: 33468309 - 14
Long-Term Outcome After Partial Splenectomy Compared to Total Splenectomy in Children With Spherocytosis.
Tessier B, Bonnard A, Hery G, et al.
Journal of pediatric surgery 2025; (60(11)):162508 doi:10.1016/j.jpedsurg.2025.162508.
PMID: 40774475 - 15
Association between hereditary spherocytosis and gallstone disease: Pathophysiology, diagnosis, and management.
Cong S, Wang YN, Wang JR, Duan RH
World journal of gastrointestinal surgery 2025; (17(7)):105033 doi:10.4240/wjgs.v17.i7.105033.
PMID: 40740904 - 16
Laparoscopic cholecystectomy for symptomatic cholelithiasis in children and adolescents: analysis of 50 cases from a single institution.
Almeida RQ, Gerardi Filho VA, Dias JLF, et al.
Acta cirurgica brasileira 2024; (39()):e394124 doi:10.1590/acb394124.
PMID: 39046043 - 17
Treatment of asymptomatic gallstones in children with hereditary spherocytosis requiring splenectomy.
Liu Y, Jin S, Li Y, et al.
Journal of pediatric surgery 2023; (58(4)):756-761 doi:10.1016/j.jpedsurg.2022.11.012.
PMID: 36588038 - 18
Pediatric splenectomy for hematologic disorders: two-decade experience and prophylactic cholecystectomy outcomes.
Uzaslan O, Hakalmaz AE, Ocak S, et al.
BMC surgery 2025; (25(1)):359 doi:10.1186/s12893-025-03107-0.
PMID: 40783526 - 19
Medical complications following splenectomy.
Buzelé R, Barbier L, Sauvanet A, Fantin B
Journal of visceral surgery 2016; (153(4)):277-86.
PMID: 27289254
This page explains treatment and surgical options for hereditary spherocytosis for educational purposes only. Always discuss your specific symptoms, transfusion needs, and surgical timing with your hematologist and surgical team.
Stay up to date
Get notified when new research about Hereditary spherocytosis is published.
No spam. Unsubscribe anytime.